The Asia Pacific feed vitamin market is expected to reach USD 4.1 billion in 2023 from USD 3.48 billion in 2018 by growing at a CAGR of 3.36%. Asia Pacific is the largest market for animal feed vitamins market owing to the heavy livestock population and poultry feed is the largest segment for the vitamin market. It is also the fastest growing region in the market mainly due to increased demand for quality meat and increased mass production of meat.
Feed vitamins provide essential vitamins to the farm animals which they are unable to take from their regular diet in adequate amount. The modern feeds are made out of specific and best ingredients to provide high nutrition level, better health and disease prevention. Feed vitamins are mainly used by dairy animals and poultry animals.
The key drivers for the market are necessity of vitamins for livestock, rise in health concern due to disease outbreak in livestock, increase in demand for high quality meat, egg and milk. While in the Asia pacific region the population is a major factor for increase in production of feed vitamin. Restraint for the market are high cost of raw materials and processing.
Mainly the feed vitamin market is segmented into type of livestock including swine, ruminants, poultry, aquatic animals and others. They are either single functioned or multi functioned. On the basis of formulation, they are divided into liquid, dry and others (powder, pellet). Poultry is the largest and fastest growing segment due to increase in population and hence increase in the demand of meant and egg.
Leading companies in the market are S.A.S, Aland BASF SE, CSPC Pharmaceutical Group Ltd., Zhejiand Medicine company Ltd., Pharmative LLC, North China pharmaceutical corporation, Archer Daniels Midland company, Evonik industries and DSM N.V.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Vitamin Type
5.1.1 Vitamin A
5.1.2 Vitamin B
5.1.3 Vitamin C
5.1.4 Vitamin D
5.1.5 Vitamin E
5.1.6 Vitamin K
5.2 By Livestock Type
5.2.1 Swine
5.2.2 Ruminants
5.2.3 Poultry
5.2.4 Aquatic Animals
5.2.5 Others
5.3 By Formulation
5.3.1 Liquid
5.3.2 Dry
5.3.3 Others (Powder, Pellet)
5.4 By Function
5.4.1 Single Functioned
5.4.2 Multi Functioned
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 Australia
6.6 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 S.A.S
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Aland BASF SE
8.3 CSPC Pharmaceutical Group Ltd.
8.4 Zhejiand Medicine Company Ltd.
8.5 Pharmative LLC
8.6 North China pharmaceutical Corporation
8.7 Archer Daniels Midland Company
8.8 Evonik industries
8.9 DSM N.V.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
